EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide Receptor

George J Farmer, Julie Sanchez, Annabell Millns, Tamzin Antony, Meritxell Canals, J Robert Lane iD, Shailesh N Mistry iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c02707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von George J Farmer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Physiology, Pharmacology and Neuroscience, Medical School, School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, U.K. Hauptthemen laut MEDLINE: Receptors, Opioid, Drug Design, Narcotic Antagonists, Fluorescent Dyes. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nociceptin/orphanin FQ opioid peptide receptor (NOPr) is a member of the opioid receptor family under investigation for the treatment of depression, Parkinson's disease, addiction, and pain. Opioid analgesics such as morphine act through μ-opioid receptor (MOPr) activation but cause MOPr-driven side effects that include respiratory depression, tolerance, addiction, and constipation. Bivalent NOPr/MOPr agonists have been shown to confer effective analgesia with an improved side effect profile. However, the development of new NOPr-targeting drugs is challenged by a paucity of pharmacological tools to characterize NOPr-ligands and visualize receptor expression. We report the design, synthesis, and pharmacological evaluation of the first high affinity small molecule NOPr-targeting fluorescent ligands, based on the antagonist: (2R)-1-(phenylmethyl)-N-(3-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylpropyl)pyrrolidine-2-carboxamide (C24). These ligands display excellent selectivity for the NOPr against MOPr, δ (DOPr), and κ (KOPr) opioid receptors and are effective tracers for competition binding assays to evaluate NOPr-ligand affinity and in live cell imaging to visualize NOPr expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, OpioidDrug DesignNarcotic AntagonistsFluorescent DyesNociceptin ReceptorHumansLigandsAnimalsStructure-Activity RelationshipHEK293 CellsCHO CellsCricetulusReceptors, Opioid, mu

Substanzen

Receptors, OpioidNociceptin ReceptorNarcotic AntagonistsFluorescent DyesLigandsReceptors, Opioid, mu

Autor:innen und Institutionen

  • Division of Physiology, Pharmacology and Neuroscience, Medical School, School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, U.K.
  • Division of Biomolecular Science and Medicinal Chemistry, School of Pharmacy, University of Nottingham Biodiscovery Institute, University Park, University of Nottingham, Nottingham NG7 2RD, U.K.
  • Centre of Membrane Proteins and Receptors, School of Life Sciences, University of Nottingham, Medical School, Queens Medical Centre, Nottingham NG7 2UH, U.K.

ORCID-Profile: J Robert Lane, Shailesh N Mistry

Förderung

  • Wellcome Trust

Zitieren

APA

Farmer, G. J., Sanchez, J., Millns, A., Antony, T., Canals, M., Lane, J. R., & Mistry, S. N. (2026). Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide Receptor. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02707

Vancouver

Farmer GJ, Sanchez J, Millns A, Antony T, Canals M, Lane JR, et al. Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide Receptor. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c02707

BibTeX
@article{Farmer2026,
  author = {Farmer, George J and Sanchez, Julie and Millns, Annabell and Antony, Tamzin and Canals, Meritxell and Lane, J Robert and Mistry, Shailesh N},
  title = {Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide Receptor},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c02707}
}
Kostenlos starten →